Manufacturing Execution System in Life Sciences Market is expected to reach USD 6.0 billion by 2030. The adoption of manufacturing execution system (MES) is emerging as a key factor in the life science industry, helping to improve efficiency, compliance, and innovation across production processes. In North America, MES implementation is experiencing a significant surge in the industry, highlighting its transformative impact on manufacturing workflows.